Advertisement

Frequency, types and severity of medication use-related problems among medical outpatients in Nigeria

  • Kazeem B. YusuffEmail author
  • Fola Tayo
Research Article

Abstract

Objectives To determine the frequency, types and severity of medications use-related problems among medical outpatients in a tertiary care setting in southwestern Nigeria. Setting Medical outpatient clinics of a 900-bed Teaching Hospital located in Ibadan, Southwestern Nigeria. Methods A prospective cross-sectional medication use review was conducted by ten pharmacists for 400 randomly selected medical outpatients over a 4 week period at a 900-bed premier teaching hospital located in Ibadan, Nigeria. Severity assessment of medication use-related problems was done by 3 independent assessors with a modified severity index. Main outcome measure Frequency, types and severity of medication use-related problems identified through pharmacist-initiated medication use review. Results Of the 400 randomly selected patients, 324 (81.0%) consented and were interviewed. One hundred and sixty-three (50.3%) of the cohort were males and 161 (49.7%) were females; with mean ages 51.5 ± 17.6 and 52.1 ± 17.4 years respectively. Median no. of drugs prescribed per patient per day was 4 (Minimum–Maximum, 1–7). About 27.5% were self medicating with orthodox (prescription-only and over-the-counter) and/or herbal medicines; and only 14.6% claimed disclosure to their physicians. The proportion of patients self medicating with orthodox medicines was significantly higher (P < 0.0001). Two hundred and twenty-six medication use-related problems were identified from 58.6% of patients, but the highest number (5) was identified among 2.6% of patients. The frequency of medication use-related problems appear strongly related to the number of medicines prescribed (r = 0.71, P = 0.006). The majority of medication use-related problems were ranked as potentially harmful [Inter-rater reliability coefficient: Gwet AC1: 0.7214 (P ≤ 0.001)]. Non-adherence (43.8%), problems associated with self medication (39.3%) and adverse drug reactions (15.6%) were the most frequent. Unauthorized drug holidays (46.5%) and stoppage of prescribed prescription-only medications for local herbs (29.3%) were the major consequences of non-adherence. Potentially harmful drug-disease interactions were the most frequent medication use-related problems arising from self medication (40.4%). Conclusion Potentially harmful medication use-related problems are frequently encountered among medical outpatients in Nigeria. The institutionalization of medication use review and the devolution of this task to pharmacists may prove beneficial in optimizing outcomes of medication use in Nigeria.

Keywords

Drug-related problems DRPs Outpatients Medication use-related problems Nigeria 

Notes

Acknowledgments

To Mrs. B. Alao, Fateye Babasola, Prof. B. Salako and Dr. F. Fehintola; and the Master of Pharmacy students (02/03 set) for their contributions toward the successful conduct of the study.

Funding

None.

Conflicts of interest

None declared.

References

  1. 1.
    Management Sciences for Health/World Health Organization/Action Programme on Essential Drugs (MSH/WHO/DAP). Managing drug supply. 2nd ed. Hartford: C.T. Kumarian; 1997. ISBN 1-56549-047-9.Google Scholar
  2. 2.
    Dukes MNG, editor. Drug utilization studies: methods and uses. WHO regional publications, European series no. 45. Copenhagen: World Health Organization; 1993. ISBN 9289013087.Google Scholar
  3. 3.
    Institute of Medicine. To Err is human: building a safer health system. In: Kohn LT, Corrigan JM, Donaldson MS, editors. Report of the committee on quality of health care in America. Washington, DC: National Academy Press; 1999. ISBN 0-309-06837-1.Google Scholar
  4. 4.
    Department of Health. An organization with a memory. Report of an expert group on learning from adverse event in the NHS. London: The Stationery Office; 2000. ISBN 011-322441-9.Google Scholar
  5. 5.
    Ebbesen J, Buajordet I, Erikssen J, Brors O, Hilberg T, Svaar H, Sandvik L. Drug-related deaths in a department of internal medicine. Arch Intern Med. 2001;161:2317–23.PubMedCrossRefGoogle Scholar
  6. 6.
    Johnson JA, Bootman JL. Drug-related morbidity and mortality: a cost of illness model. Arch Intern Med. 1995;155:1949–56.PubMedCrossRefGoogle Scholar
  7. 7.
    Leape LL, Brennan TA, Laird N. The nature of adverse events in hospitalized patients: results from the Harvard Medical Practice Study 11. N Engl J Med. 1991;324:377–84.PubMedCrossRefGoogle Scholar
  8. 8.
    Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc. 2001;41:192–9.Google Scholar
  9. 9.
    Nelson KM, Talbert RL. Drug-related hospital admissions. Pharmacotherapy. 1996;16:701–7.PubMedGoogle Scholar
  10. 10.
    Ebbesen J, Buajordet I, Erikssen J, et al. Drug-related deaths in a department of internal medicine. Arch Intern Med. 2001;161:2317–23.PubMedCrossRefGoogle Scholar
  11. 11.
    Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279:1200–5.PubMedCrossRefGoogle Scholar
  12. 12.
    Strand LM, Morley PC, Cipolle RJ. Drug-related problems: their structure and function. DICP Ann Pharmacother. 1990;24:1093–7.Google Scholar
  13. 13.
    Erhun WO, Babalola OO, Erhun MO. Drug regulation and control in Nigeria: the challenge of counterfeit drugs. J health Popul Dev Count. 2001;4(2):23–34.Google Scholar
  14. 14.
    Erhun WO, Agunedu CO. Procurement and sale of drugs in a market-place. Nig J Pharm. 1995;26:30–2.Google Scholar
  15. 15.
    Ajayi IO, Falade CO. Pre-hospital treatment of febrile illness in children attending the general outpatient clinic, university college hospital, Ibadan, Nigeria. Afr J Med Med Sci. 2006;35:85–91.PubMedGoogle Scholar
  16. 16.
    Bamigboye EA, Amoran OE, Yusuff OB. Self medication practices among workers in a tertiary hospital in Nigeria. Afr J Med Med Sci. 2006;35:411–5.Google Scholar
  17. 17.
    Buabeng OK, Matowe L, Plange-Rhule J. Unaffordable drug prices: the major cause of non-compliance with hypertension medication in Ghana. J Pharm Pharmaceut Sci. 2004;7(3):350–2.Google Scholar
  18. 18.
    Khalil SA, Elzubier AG. Drug compliance and among hypertensive patients in Tabuk, Saudi Arabia. J Hypertens. 1997;15(5):561–5.PubMedCrossRefGoogle Scholar
  19. 19.
    Yusuff KB, Abdrahman A. Assessing patient adherence to anti-hypertensive drug therapy: can a structured pharmacist-conducted interview separate the wheat from the chaff? Int J Pharm Pract. 2007;15:295–300.CrossRefGoogle Scholar
  20. 20.
    Yusuff KB, Obe B, Joseph YB. Adherence to anti-diabetic drug therapy and self management practices among type-2 diabetics in a Nigerian tertiary care setting. Pharm World Sci. 2008;30:876–83.PubMedCrossRefGoogle Scholar
  21. 21.
    Youssef RM, Muobarak II. Patterns and determinants of treatment compliance among hypertensive patients. East Mediterr Health J. 2002;8(4–5):579–92.PubMedGoogle Scholar
  22. 22.
    National Coordinating Council for Medication Error Reporting and Prevention (NCCMERP). NCC MERP Index for categorizing medication errors 2001. www.nccmerp.org/medErrorCatIndex.html. Accessed 2004 May 27).
  23. 23.
    Lenon C, Hughes CM, Johnston GD, McElnay JC. Identification of psychological factors which influence patient adherence with antihypertensive medication. Int J Pharm Pract. 2001;9:R8.CrossRefGoogle Scholar
  24. 24.
    Colley CA, Lucas LM. Polypharmacy: the cure becomes the disease. J Gen Intern Med. 1993;8:278–83.PubMedCrossRefGoogle Scholar
  25. 25.
    Awad A, Eltayeb L, Matowe LT. Self-medication with antibiotics and antimalarials in the community of Khartoum State, Sudan. J Pharm Pharmaceut Sci. 2005;8(2):326–31.Google Scholar
  26. 26.
    Salako LA, Brieger WR, Afolabi BM, Umeh RE, Agomo PU. Treatment of childhood fevers and other illnesses in three rural Nigerian communities. J Trop Pediatr. 2001;47:230–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Nwanko SO, Fakeye TO. Evaluation of the use of herbal medicines among hypertensive patients attending a secondary health are facility in Nigeria. Int J Pharm Pract. 2009;17(2):101–5.CrossRefGoogle Scholar
  28. 28.
    Ajayi IO, Olumide EA, Oyediran O. Patient satisfaction with the services provided at a general outpatient clinic, Ibadan, Oyo state, Nigeria. Afri J Med Med Sci. 2005;34:133–40.Google Scholar
  29. 29.
    Federal Ministry of Health (FMOH). National drug policy (NDP). Abuja: FMOH; 2005.Google Scholar
  30. 30.
    Cook TF, Frighetto L, Marra CA, Jewesson TJ. Pattern of use and patients’ attitude towards complementary medications: a survey of adult general medicine patients at a major Canadian teaching hospital. Can J Clin Pharmacol. 2002;9(4):183–9.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2011

Authors and Affiliations

  1. 1.Department of Pharmacy Administration and Practice, Faculty of PharmacyRhodes UniversityGrahamstownSouth Africa
  2. 2.Department of Clinical Pharmacy and Pharmacy Administration, Faculty of PharmacyUniversity of IbadanIbadanNigeria
  3. 3.Department of Clinical Pharmacy and Biopharmacy, Faculty of PharmacyUniversity of LagosLagosNigeria

Personalised recommendations